Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSynairgen Share News (SNG)

Synairgen Information

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.76
Bid: 5.02
Ask: 5.76
Change: 0.00 (0.00%)
Spread: 0.74 (14.741%)
Open: 5.76
High: 0.00
Low: 0.00
Prev. Close: 5.76
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 20th Apr 2023 15:41

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
5 Dec 2012 11:10

Synairgen reports 'significant progress'

Synairgen, a respiratory drug discovery and development company, has reported 'significant progress' since the end of June. The firm said that discussions with potential licensing partners for its SNG001 product have progressed, the company has engaged with the US government to investigate the pote

Read more
18 Jul 2012 09:39

Synairgen raises 2.5m pounds from placing

Synairgen, a Southampton-based research firm, has placed around 5.56m shares at 45p each, enabling the firm to progress with its primary programme following the successful clinical trial results of an asthma treatment product. The placing has raised £2.5m before expenses. In a related transaction,

Read more
19 Apr 2012 10:22

Synairgen no wheeze as asthma drug trial boosts shares

Southampton based research firm, Synairgen, has rocketed in morning trading after announcing results for a treatment which could protect asthmatics from respiratory virus infections. The drug, called SNG001, stops infections like the common cold spreading to patients' lungs, which is often the caus

Read more
29 Jan 2011 14:04

Takeover targets named

Hold on tight, a wave of patent expiries and generic competition could spark another round of consolidation in the pharma and medical devices sector this year. Billions of dollars have been spent on takeovers or pumped into new issues in recent months as confidence in the recovery grows and cash-ri

Read more
29 Jul 2010 12:51

Small caps round-up: Plantic Technologies, Acal, Anglesey

Shares in Plantic Technologies soared more than 50% after the biodegradeable plastics outfit agreed an 8p per share offer from a company controlled by Gordon Merchant, one of its directors. Acal, which provides technology products and services across Europe and South Africa, said underlying sales

Read more
29 Jul 2010 07:56

Synairgen FY Net Loss GBP2.6M Vs Loss GBP2.5M

LONDON (Dow Jones)--Synairgen PLC (SNG.LN), a respiratory drug discovery and development company with a particular focus on viral defense, Thursday reported a full year net loss of GBP2.6 million, compared with a loss of GBP2.5 million the previous year. MAIN FACTS: -Research and development

Read more
17 May 2010 13:02

Small caps: Cove Energy, Synairgen, Wilmington...

PR specialist Freshwater cut the dividend as profits fell to £32,000 from £106,000 in the six months to end February. Revenues fell to £3.66m from £4.51m. "While the economic environment remains challenging, Freshwater is seeing greater stability and growth potential in most of its markets. Alongsi

Read more
6 May 2010 12:49

Small caps round-up: Griffin Mining, Energy XXI

Griffin Mining posted a rise in profits in the year to December 31 despite a slide in revenues following the collapse in metals prices in late 2008. The company, which operates the Caijiaying zinc-gold mine in China, posted a pre-tax profit of $7.2m, up from $7m in 2008, even as revenues fell to $2

Read more
9 Nov 2009 16:31

London close: Miners power Footsie gains

Mining stocks were at the vanguard of a strong advance from FTSE 100 as commodity prices were boosted by plans outlined by world leaders over the weekend to continue with stimulus measures. Kazakhmys, Fresnillo, Rio Tinto and Vedanta were some of the best performers in the mining sector. Mining g

Read more
9 Nov 2009 14:23

London afternoon: Cadbury rejects Kraft bid

After all the waiting and speculation, the formal bid for Cadbury from US group Kraft Foods proved a disappointment, but it has not dampened sentiment in a buoyant London market. Kraft formally announced a bid for Cadbury on the same terms as the indicative offer announced at the beginning of Septe

Read more
9 Nov 2009 08:42

Synairgen hails swine flu result

The share price of respiratory disease drug developer Synairgen more than doubled in early trading on Monday after positive developments for its inhaled interferon beta programme. Laboratory experiments confirmed the antiviral potency of IFN-beta against 2009 H1N1, better known as ‘swine flu’. The

Read more
27 May 2009 07:59

Small caps round-up: LonZim, Lees Foods, blinkx ...

Zimbabwe-focused investment company LonZim said it is well-placed to benefit from any upturn in the southern African country's economy after investing in several sectors in the six months to February 28. The company posted a pre-tax loss of £911,000 as it invested in telecoms, aviation and hotel se

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.